Issue 8, 2018

Molecular insights into the interaction of Hsp90 with allosteric inhibitors targeting the C-terminal domain

Abstract

Unique to targeting the C-terminal domain of Hsp90 (C-Hsp90) is the ability to uncouple the cytotoxic and cytoprotective outcomes of Hsp90 modulation. After the identification of novobiocin as a C-Hsp90 interacting ligand a diverse gamut of novologues emerged, from which KU-32 and KU-596 exhibited strong neuroprotective activity. However, further development of these ligands is hampered by the difficulty to obtain structural information on their complexes with Hsp90. Using saturation transfer difference (STD) NMR spectroscopy, we found that the primary binding epitopes of KU-32 and KU596 map at the ring systems of the ligands and specifically the coumarin and biphenyl structures, respectively. Based on both relative and absolute STD effects, we identified KU-596 sites that can be explored to design novel third-generation novologues. In addition, chemical shift perturbations obtained by methyl-TROSY reveal that novologues bind at the cryptic, C-Hsp90 ATP-binding pocket and produce global, long-range structural rearrangements to dimeric Hsp90.

Graphical abstract: Molecular insights into the interaction of Hsp90 with allosteric inhibitors targeting the C-terminal domain

Supplementary files

Article information

Article type
Research Article
Submitted
18 Mar 2018
Accepted
29 Jun 2018
First published
02 Jul 2018

Med. Chem. Commun., 2018,9, 1323-1331

Molecular insights into the interaction of Hsp90 with allosteric inhibitors targeting the C-terminal domain

V. Kumar MV, R. Ebna Noor, R. E. Davis, Z. Zhang, E. Sipavicius, D. Keramisanou, B. S. J. Blagg and I. Gelis, Med. Chem. Commun., 2018, 9, 1323 DOI: 10.1039/C8MD00151K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements